Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Research & Development: 2009-2025

Historic Research & Development for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $24.2 million.

  • BIO-TECHNE's Research & Development rose 1.56% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.9 million, marking a year-over-year increase of 3.45%. This contributed to the annual value of $99.5 million for FY2025, which is 2.93% up from last year.
  • As of Q3 2025, BIO-TECHNE's Research & Development stood at $24.2 million, which was down 6.88% from $26.0 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Research & Development ranged from a high of $26.0 million in Q2 2025 and a low of $17.1 million during Q1 2021.
  • Over the past 3 years, BIO-TECHNE's median Research & Development value was $24.0 million (recorded in 2023), while the average stood at $24.2 million.
  • Per our database at Business Quant, BIO-TECHNE's Research & Development soared by 34.65% in 2021 and then fell by 4.59% in 2025.
  • BIO-TECHNE's Research & Development (Quarterly) stood at $20.6 million in 2021, then climbed by 8.76% to $22.5 million in 2022, then climbed by 2.03% to $22.9 million in 2023, then grew by 9.16% to $25.0 million in 2024, then grew by 1.56% to $24.2 million in 2025.
  • Its last three reported values are $24.2 million in Q3 2025, $26.0 million for Q2 2025, and $24.6 million during Q1 2025.